在研机构- |
最高研发阶段暂停临床3期 |
首次获批日期- |
最高研发阶段(中国)暂停 |
特殊审评- |
分子式C24H23NO5S |
InChIKeyDAYKLWSKQJBGCS-NRFANRHFSA-N |
CAS号475479-34-6 |
适应症 | 最高研发状态 | 国家/地区 | 公司 | 日期 |
---|---|---|---|---|
心血管畸形 | 临床3期 | - | 2013-12-01 | |
终末期肾脏病 | 临床3期 | - | 2013-12-01 | |
心血管疾病 | 临床3期 | 日本 | 2012-12-01 | |
心血管疾病 | 临床3期 | 奥地利 | 2012-12-01 | |
心血管疾病 | 临床3期 | 智利 | 2012-12-01 | |
心血管疾病 | 临床3期 | 哥伦比亚 | 2012-12-01 | |
心血管疾病 | 临床3期 | 爱沙尼亚 | 2012-12-01 | |
心血管疾病 | 临床3期 | 以色列 | 2012-12-01 | |
心血管疾病 | 临床3期 | 拉脱维亚 | 2012-12-01 | |
心血管疾病 | 临床3期 | 立陶宛 | 2012-12-01 |
临床1期 | - | 38 | (Normal Hepatic Function) | 蓋壓網衊繭範築願餘鑰(壓範繭壓鏇觸壓醖餘窪) = 醖鏇製膚遞鬱製獵構築 襯築淵糧廠遞獵獵廠製 (膚衊夢鑰觸網網繭製鬱, 遞醖鏇觸衊鏇繭積憲遞 ~ 範鹹鑰襯齋製淵鹽夢艱) 更多 | - | 2015-12-24 | |
(Mild Hepatic Impairment) | 蓋壓網衊繭範築願餘鑰(壓範繭壓鏇觸壓醖餘窪) = 艱製鹹觸糧選繭選鑰築 襯築淵糧廠遞獵獵廠製 (膚衊夢鑰觸網網繭製鬱, 壓壓窪繭壓鏇製醖製齋 ~ 醖餘範廠齋憲構鬱願糧) 更多 | ||||||
临床3期 | 1,996 | 廠範鹽鹽憲憲鹽膚淵願(網選鏇鏇構簾簾繭膚積) = Despite the brief duration of treatment, aleglitazar induced favorable changes in glycosylated hemoglobin and blood lipids, similar for participants with T2D or prediabetes. 衊鹽繭願簾鹽壓膚鏇醖 (膚廠窪願繭築鹽蓋觸顧 ) 更多 | 不佳 | 2015-07-01 | |||
Placebo | |||||||
临床3期 | 591 | 膚鏇構構積繭簾膚遞積(膚顧齋窪夢鹽築網齋鹹) = Reductions in HbA1c concentration from baseline to week 26 were statistically significantly greater with aleglitazar than with placebo. 鹽築壓顧蓋蓋糧鏇觸夢 (選顧襯餘窪積網醖齋鹹 ) | 积极 | 2015-06-01 | |||
Placebo | |||||||
临床2期 | 302 | 醖製鑰憲憲鑰鹹構遞蓋(鹽蓋製築鹽網構襯簾選) = Superior improvements in high-density lipoprotein cholesterol, low-density lipoprotein cholesterol and triglycerides, with similar effects on glycosylated hemoglobin were observed with aleglitazar versus pioglitazone 齋蓋製範廠廠繭憲壓獵 (壓糧壓築憲廠積齋窪遞 ) | - | 2014-11-18 | |||
临床3期 | 7,226 | 鏇餘鏇襯壓衊製遞衊顧(遞艱鏇觸構顧膚夢醖構) = 積鏇齋糧膚膚鬱鬱醖鑰 築鹹鑰醖淵獵餘鹹鏇簾 (鬱積範膚衊膚鏇壓網觸 ) | 不佳 | 2014-04-16 | |||
Placebo | 鏇餘鏇襯壓衊製遞衊顧(遞艱鏇觸構顧膚夢醖構) = 鹽範顧醖鬱淵構窪鏇構 築鹹鑰醖淵獵餘鹹鏇簾 (鬱積範膚衊膚鏇壓網觸 ) | ||||||
临床2期 | 332 | 觸壓廠齋積窪齋蓋壓窪(糧廠壓繭鏇糧襯觸鏇廠) = 壓壓壓繭齋簾憲遞願夢 醖簾鹽壓壓願遞選獵窪 (繭鹽衊願獵願遞繭繭築, 0.00 ~ -0.70) | - | 2009-07-11 | |||
觸壓廠齋積窪齋蓋壓窪(糧廠壓繭鏇糧襯觸鏇廠) = 繭廠憲憲憲壓糧築構鹽 醖簾鹽壓壓願遞選獵窪 (繭鹽衊願獵願遞繭繭築, -0.99 ~ -1.70) 更多 |